Table 4.
Frequency of Melan-A/Mart-127–35–specific CTL Effectors on Day 42 of Bulk Culture after T Cell Activation with Different APCs
APCs | Peptide used to load APCs in bulk culture | Frequency, after bulk culture, of peptide-specific CTL effectors directed to | |
---|---|---|---|
Melan-A/Mart-127–35 peptide | Influenza matrix58–66 peptide | ||
T2 cells | Melan-A/Mart-127–35 | 1/69 | ND |
CD34+-derived autologous DCs | Melan-A/Mart-127–35 | 1/63 | ND |
Monocyte-derived autologous DCs | Melan-A/Mart-127–35 | 1/142 | ND |
Fresh autologous monocytes | Melan-A/Mart-127–35 | <1/200,000 | ND |
Fresh autologous monocytes | Flu matrix58–66 | 1/1,190 |
Frequency of Melan-A/Mart-127–35- and Flu matrix58–66–specific effectors was determined respectively on days 42 and 21 of bulk T cell culture. Responder lymphocytes were from one of the patients (patient 7) in the low CTLp frequency subset. Phenotype of all APCs was checked by flow cytometry. CD34+ and monocyte-derived DCs expressed CD1a, CD40, CD80, CD86, CD54, HLA-DR, and HLA-DQ antigens. T2 cells expressed CD40, CD80, CD86, and CD54. CD14 was expressed only by monocytes, which were also positive for HLA-DR and CD54 but lacked CD40, CD80, CD86, and HLA-DQ antigens.